Digital health has far more to offer than just Digital Therapeutics
Disrupting pharma's digital innovation mindset Digital Therapeutics DTx have stormed onto the healthcare scene, promising groundbreaking change with their clinically validated, tech-driven interventions. But here’s the burning question: Is this the only path to digital health innovation for pharma? Are companies locking themselves into an expensive, heavily regulated, slow-moving gamble, while more flexible and scalable solutions with potentially greater impact on patient outcomes are waiting in the wings?
The Digital Therapeutics Alliance DTA defines DTx as “software intended to treat or alleviate a disease, disorder, condition, or injury through a medical intervention that has a demonstrable positive therapeutic impact” [1].
Are DTx the exclusive gateway for pharma to deliver impactful results faster?
Download our latest position paper
- Challenges of developping DTx
- Successfull DTx examples
- Alternatives to DTx
